BESREMi
Ropeginterferon alfa-2b · PharmaEssentia USA
PRESCRIPTION ONLY (USA)BESREMi ingredients
| Active ingredient | Strength |
|---|---|
| Ropeginterferon Alfa-2B | 500 ug/mL |
What BESREMi is used for
BESREMi is a specialist medicine (interferon alfa-2b). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- BESREMi
- Generic name
- Ropeginterferon alfa-2b
- Made by
- PharmaEssentia USA
- Forms
- Injection
- Given
- Subcutaneous
- Drug class
- Interferon alfa-2b
- FDA approval
- Biologic licence (BLA) BLA761166
- On the US market since
- 2021
Official information
- BESREMi prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Ropeginterferon alfa-2b)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is BESREMi?
BESREMi (Ropeginterferon alfa-2b) is a specialist medicine made by PharmaEssentia USA, approved by the US FDA.
What are the ingredients of BESREMi?
BESREMi contains Ropeginterferon Alfa-2B (500 ug/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA